Form 8-K - Current report:
SEC Accession No. 0001513162-22-000056
Filing Date
2022-04-19
Accepted
2022-04-19 16:00:34
Documents
14
Period of Report
2022-04-19
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bmra-20220419.htm   iXBRL 8-K 34469
2 EXHIBIT 16.1 exhibit16_1.htm EX-16.1 4144
  Complete submission text file 0001513162-22-000056.txt   179246

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmra-20220419.xsd EX-101.SCH 3179
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmra-20220419_def.xml EX-101.DEF 10555
5 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bmra-20220419_lab.xml EX-101.LAB 21439
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmra-20220419_pre.xml EX-101.PRE 10917
8 EXTRACTED XBRL INSTANCE DOCUMENT bmra-20220419_htm.xml XML 2443
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9496452111
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-37863 | Film No.: 22834952
SIC: 2835 In Vitro & In Vivo Diagnostic Substances